Establishment Labs Holdings Inc. (NASDAQ:ESTA) Stock Holdings Lessened by Nantahala Capital Management LLC

Nantahala Capital Management LLC trimmed its position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 29.9% during the 4th quarter, Holdings Channel reports. The fund owned 1,654,470 shares of the company’s stock after selling 704,671 shares during the period. Establishment Labs makes up approximately 3.3% of Nantahala Capital Management LLC’s investment portfolio, making the stock its 3rd biggest position. Nantahala Capital Management LLC owned 0.06% of Establishment Labs worth $76,221,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of ESTA. Capital Research Global Investors raised its holdings in shares of Establishment Labs by 29.3% during the 4th quarter. Capital Research Global Investors now owns 1,911,525 shares of the company’s stock worth $88,064,000 after acquiring an additional 433,484 shares in the last quarter. Voya Investment Management LLC raised its holdings in shares of Establishment Labs by 7,249.5% during the 4th quarter. Voya Investment Management LLC now owns 408,262 shares of the company’s stock worth $18,809,000 after acquiring an additional 402,707 shares in the last quarter. Assenagon Asset Management S.A. purchased a new stake in shares of Establishment Labs during the 4th quarter worth approximately $12,898,000. William Blair Investment Management LLC raised its holdings in shares of Establishment Labs by 44.1% during the 4th quarter. William Blair Investment Management LLC now owns 812,825 shares of the company’s stock worth $37,447,000 after acquiring an additional 248,888 shares in the last quarter. Finally, Boothbay Fund Management LLC raised its holdings in shares of Establishment Labs by 68.8% during the 4th quarter. Boothbay Fund Management LLC now owns 525,248 shares of the company’s stock worth $24,198,000 after acquiring an additional 214,119 shares in the last quarter. 72.91% of the stock is owned by hedge funds and other institutional investors.

Establishment Labs Price Performance

Establishment Labs stock opened at $29.97 on Monday. The stock has a market cap of $864.51 million, a price-to-earnings ratio of -11.62 and a beta of 0.77. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. Establishment Labs Holdings Inc. has a 1 year low of $26.56 and a 1 year high of $60.12. The firm has a 50-day moving average of $36.09 and a two-hundred day moving average of $39.21.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings data on Wednesday, February 26th. The company reported ($0.98) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.64) by ($0.34). Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The company had revenue of $44.51 million during the quarter, compared to analysts’ expectations of $44.45 million. On average, research analysts forecast that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the stock. Needham & Company LLC assumed coverage on shares of Establishment Labs in a research note on Monday, April 14th. They issued a “hold” rating on the stock. Stephens reiterated an “overweight” rating and set a $52.00 price target on shares of Establishment Labs in a report on Thursday, March 6th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $57.40.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.